Literature DB >> 11976502

Crystallization of the functional domain of human thrombopoietin using an antigen-binding fragment derived from neutralizing monoclonal antibody.

Ryota Kuroki1, Masako Hirose, Yoichi Kato, Michael D Feese, Taro Tamada, Hideki Shigematsu, Hiroshi Watarai, Yoshitake Maeda, Tomoyuki Tahara, Takashi Kato, Hiroshi Miyazaki.   

Abstract

Thrombopoietin (TPO) is a cytokine which primarily stimulates megakaryocytopoiesis and thrombopoiesis. The functional domain of TPO (TPO(163)) consisting of the N-terminal 163 amino acids was prepared and crystallized. Since the crystallization of TPO(163) was unsuccessful using the standard screening methods, a Fab fragment derived from a neutralizing monoclonal antibody was used for crystallization. It was found that the TPO(163)-Fab complex crystallized reproducibly in 0.1 M potassium phosphate buffer pH 6.0 containing 20-25% polyethylene glycol 4000. Thin crystals (0.2 x 0.2 x 0.02 mm) grew in two space groups: P2(1), with unit-cell parameters a = 133.20, b = 46.71, c = 191.47 A, beta = 90.24 degrees, and C2, with unit-cell parameters a = 131.71, b = 46.48, c = 184.63 A, beta = 90.42 degrees. The results of a molecular-replacement analysis indicate that the Fab molecules interact with each other and provide a suitable interface for crystallization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976502     DOI: 10.1107/s0907444902004791

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

1.  'Crystal lattice engineering,' an approach to engineer protein crystal contacts by creating intermolecular symmetry: crystallization and structure determination of a mutant human RNase 1 with a hydrophobic interface of leucines.

Authors:  Hidenori Yamada; Taro Tamada; Megumi Kosaka; Kohei Miyata; Shinya Fujiki; Masaru Tano; Masayuki Moriya; Mamoru Yamanishi; Eijiro Honjo; Hiroko Tada; Takeshi Ino; Hiroshi Yamaguchi; Junichiro Futami; Masaharu Seno; Takashi Nomoto; Tomoko Hirata; Motonobu Yoshimura; Ryota Kuroki
Journal:  Protein Sci       Date:  2007-07       Impact factor: 6.725

2.  An insight into the thermodynamic characteristics of human thrombopoietin complexation with TN1 antibody.

Authors:  Shigeki Arai; Chie Shibazaki; Motoyasu Adachi; Eijiro Honjo; Taro Tamada; Yoshitake Maeda; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Michael Blaber; Ryota Kuroki
Journal:  Protein Sci       Date:  2016-07-25       Impact factor: 6.725

3.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Authors:  Michael D Feese; Taro Tamada; Yoichi Kato; Yoshitake Maeda; Masako Hirose; Yasuko Matsukura; Hideki Shigematsu; Takanori Muto; Atsushi Matsumoto; Hiroshi Watarai; Kinya Ogami; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

4.  Thrombopoietin and its receptor in normal and neoplastic hematopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Thromb J       Date:  2016-10-04

5.  Mutagenesis of the crystal contact of acidic fibroblast growth factor.

Authors:  Eijiro Honjo; Taro Tamada; Motoyasu Adachi; Ryota Kuroki; Akshaya Meher; Michael Blaber
Journal:  J Synchrotron Radiat       Date:  2008-04-18       Impact factor: 2.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.